Ultra-High Potency: Ultra-potent APIs are reshaping both pharma lexicon and the industry itself

February 27, 2026

With 30-50% of new molecules now classified as high potency, the ambiguity affects facility selection, program costs, and safety. This paper explores why "ultra-high potency" has emerged as essential terminology for navigating today's extreme potency landscape—and what it means for CDMOs manufacturing breakthrough therapies.

Download the Document

    Please fill out the information below to access this content. If you are already registered, or have accessed content before, and this information will be filled out for you.
  • By submitting this form, you consent to Tablets and Capsules storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time